标题
MicroRNA-33 regulates sterol regulatory element-binding protein 1 expression in mice
作者
关键词
-
出版物
Nature Communications
Volume 4, Issue 1, Pages -
出版商
Springer Nature
发表日期
2013-12-03
DOI
10.1038/ncomms3883
参考文献
相关参考文献
注意:仅列出部分参考文献,下载原文获取全部文献信息。- Anti-miR-33 Therapy Does Not Alter the Progression of Atherosclerosis in Low-Density Lipoprotein Receptor-Deficient Mice
- (2013) Tyler J. Marquart et al. ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY
- Anti-atherosclerosis or No Anti-atherosclerosis
- (2013) Anders M. Näär ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY
- Regulation of cholesterol and bile acid homeostasis by the cholesterol 7α-hydroxylase/steroid response element-binding protein 2/microRNA-33a axis in mice
- (2013) Tiangang Li et al. HEPATOLOGY
- MicroRNA‐33 Deficiency Reduces the Progression of Atherosclerotic Plaque in ApoE −/− Mice
- (2013) Takahiro Horie et al. Journal of the American Heart Association
- miR-33 controls the expression of biliary transporters, and mediates statin- and diet-induced hepatotoxicity
- (2012) Ryan M. Allen et al. EMBO Molecular Medicine
- Cidea promotes hepatic steatosis by sensing dietary fatty acids
- (2012) Linkang Zhou et al. HEPATOLOGY
- Preventing Phosphorylation of Sterol Regulatory Element-Binding Protein 1a by MAP-Kinases Protects Mice from Fatty Liver and Visceral Obesity
- (2012) Jorg Kotzka et al. PLoS One
- Liver-Specific Expression of Transcriptionally Active SREBP-1c Is Associated with Fatty Liver and Increased Visceral Fat Mass
- (2012) Birgit Knebel et al. PLoS One
- Nuclear receptor PPAR -regulated monoacylglycerol O-acyltransferase 1 (MGAT1) expression is responsible for the lipid accumulation in diet-induced hepatic steatosis
- (2012) Y. J. Lee et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Cholesterol regulation of receptor-interacting protein 140 via microRNA-33 in inflammatory cytokine production
- (2011) Ping-Chih Ho et al. FASEB JOURNAL
- Role for PPARγ in obesity-induced hepatic steatosis as determined by hepatocyte- and macrophage-specific conditional knockouts
- (2011) Eva Morán-Salvador et al. FASEB JOURNAL
- Antagonism of miR-33 in mice promotes reverse cholesterol transport and regression of atherosclerosis
- (2011) Katey J. Rayner et al. JOURNAL OF CLINICAL INVESTIGATION
- Inhibition of miR-33a/b in non-human primates raises plasma HDL and lowers VLDL triglycerides
- (2011) Katey J. Rayner et al. NATURE
- Acute doxorubicin cardiotoxicity is associated with miR-146a-induced inhibition of the neuregulin-ErbB pathway
- (2010) Takahiro Horie et al. CARDIOVASCULAR RESEARCH
- Stress-dependent cardiac remodeling occurs in the absence of microRNA-21 in mice
- (2010) David M. Patrick et al. JOURNAL OF CLINICAL INVESTIGATION
- miR-33 links SREBP-2 induction to repression of sterol transporters
- (2010) T. J. Marquart et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- MicroRNA-33 encoded by an intron of sterol regulatory element-binding protein 2 (Srebp2) regulates HDL in vivo
- (2010) T. Horie et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- MicroRNA-33 and the SREBP Host Genes Cooperate to Control Cholesterol Homeostasis
- (2010) S. H. Najafi-Shoushtari et al. SCIENCE
- MiR-33 Contributes to the Regulation of Cholesterol Homeostasis
- (2010) K. J. Rayner et al. SCIENCE
- Fibroblast Growth Factor 21 Regulates Lipolysis in White Adipose Tissue But Is Not Required for Ketogenesis and Triglyceride Clearance in Liver
- (2009) Yuhei Hotta et al. ENDOCRINOLOGY
- SREBPs: physiology and pathophysiology of the SREBP family
- (2008) Hitoshi Shimano FEBS Journal
- MicroRNA-21 contributes to myocardial disease by stimulating MAP kinase signalling in fibroblasts
- (2008) Thomas Thum et al. NATURE
Discover Peeref hubs
Discuss science. Find collaborators. Network.
Join a conversationPublish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn More